Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Vaccine against Chlamydia not far away

16.11.2009
When a woman becomes infected with Chlamydia, the first white blood cells that arrive at the scene to fight the infection are not the most effective. This is shown by a thesis from the Sahlgrenska Academy.

This discovery could pave the way for the relatively rapid development of a vaccine against Chlamydia.

"Now that we know how the body defends itself against the Chlamydia bacteria, we can develop a vaccine that optimises that defence. We have a basic understanding of how the vaccine could work, but some work remains to be done. We believe that it will take a few years before the vaccine becomes a reality," says researcher Ellen Marks, the author of the thesis.

The body defends itself against infections with a type of white cell called the T lymphocyte. When these blood cells take on the bacteria, they trigger an inflammation that can damage tissue, so there are also other similar blood cells whose main task is to reduce the inflammation and protect tissue. Ellen Marks and her colleagues are the first research team to discover that these anti-inflammatory forces predominate in the lower parts of the female genital tract, mainly mediated by a hormone called IL-10, which is highly protective against tissue damage.

"The result is that the T lymphocytes that could fight Chlamydia are not concentrated in the lower vagina, and the infection can move up towards the womb and fallopian tubes relatively unhindered," says Ellen Marks.

The research team already has a concept of how a vaccine based on this new understanding could work, and they have also tested it on mice.

"The method of administration is an important remaining issue. Previous research has shown that injections don't work, and so the vaccine will probably need to be given either as a nasal spray or in the form of a cream applied into the vagina," says Ellen Marks.

This research is being done at MIVAC (the Mucosal Immunology and Vaccine Center) - the Sahlgrenska Academy's strategic research centre. Researchers at the centre are developing novel methods of treating diseases that affect our mucous membranes.

FACTS ABOUT CHLAMYDIA
The incidence of Chlamydia infection in Sweden has increased since the mid-nineties, especially in people under the age of 24. Last year, over 40 000 new cases were reported to the Swedish Institute for Infectious Disease Control. The disease is caused by the bacterium Chlamydia trachomatis, which is transmitted by unprotected sexual contact. Many don't realise that they have been infected, because Chlamydia infection often has no symptoms at all. Without effective antibiotic treatment the infection can become chronic and may even lead to infertility.
For further information, please contact:
Ellen Marks, tel. +46 (0)31-786 63 02 or +46 (0)73-710 46 24, ellen.marks@immuno.ge.se
Supervisor:-ma
Professor Nils Lycke, tel. +46 (0)31-786 63 21, nils.lycke@microbio.gu.se
Thesis for the degree of Doctor of Medical Science at the Department of Microbiology and Immunology, Institute of Biomedicine, the Sahlgrenska Academy.

Title of thesis: Genital tract CD4+ T cells for vaccination and protection against Chlamydia trachomatis

The thesis has been defended.

You can read the complete thesis here: http://hdl.handle.net/2077/21075

Helena Aaberg | idw
Further information:
http://hdl.handle.net/2077/21075
http://www.sahlgrenska.gu.se/english/

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

Im Focus: A molecular switch may serve as new target point for cancer and diabetes therapies

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and at the University of Geneva has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases. The results of the study have just been published in the prestigious scientific journal 'Molecular Cell'.

Cell growth and cell differentiation as well as the release and efficacy of hormones such as insulin depend on the presence of lipids. Lipids are small...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

NRL's sun imaging telescopes fly on NASA Parker Solar Probe

13.08.2018 | Physics and Astronomy

UT-ORNL team makes first particle accelerator beam measurement in six dimensions

13.08.2018 | Physics and Astronomy

ASU astrophysicist helps discover that ultrahot planets have starlike atmospheres

13.08.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>